New York State Teachers Retirement System Has $2.75 Million Stock Position in ICU Medical, Inc. (NASDAQ:ICUI)

New York State Teachers Retirement System boosted its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 6.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 27,566 shares of the medical instruments supplier’s stock after purchasing an additional 1,761 shares during the quarter. New York State Teachers Retirement System owned about 0.11% of ICU Medical worth $2,749,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. American Century Companies Inc. lifted its position in shares of ICU Medical by 6.4% during the 1st quarter. American Century Companies Inc. now owns 4,035 shares of the medical instruments supplier’s stock valued at $898,000 after acquiring an additional 243 shares during the period. Group One Trading L.P. raised its holdings in shares of ICU Medical by 54.6% during the first quarter. Group One Trading L.P. now owns 566 shares of the medical instruments supplier’s stock valued at $126,000 after purchasing an additional 200 shares during the period. PNC Financial Services Group Inc. boosted its position in shares of ICU Medical by 110.5% during the 1st quarter. PNC Financial Services Group Inc. now owns 2,766 shares of the medical instruments supplier’s stock worth $615,000 after purchasing an additional 1,452 shares in the last quarter. Acadian Asset Management LLC grew its stake in shares of ICU Medical by 1,098.4% in the 1st quarter. Acadian Asset Management LLC now owns 3,020 shares of the medical instruments supplier’s stock valued at $672,000 after buying an additional 2,768 shares during the period. Finally, MetLife Investment Management LLC increased its position in ICU Medical by 33.3% in the 1st quarter. MetLife Investment Management LLC now owns 12,896 shares of the medical instruments supplier’s stock valued at $2,871,000 after buying an additional 3,221 shares in the last quarter. 96.10% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, KeyCorp boosted their price target on shares of ICU Medical from $134.00 to $136.00 and gave the company an “overweight” rating in a research note on Wednesday, February 28th. One analyst has rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $123.00.

Insider Transactions at ICU Medical

In related news, VP Daniel Woolson sold 791 shares of the stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $98.27, for a total value of $77,731.57. Following the completion of the transaction, the vice president now directly owns 13,980 shares in the company, valued at approximately $1,373,814.60. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other ICU Medical news, COO Christian B. Voigtlander sold 13,603 shares of the business’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $107.19, for a total transaction of $1,458,105.57. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Daniel Woolson sold 791 shares of the firm’s stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $98.27, for a total transaction of $77,731.57. Following the sale, the vice president now owns 13,980 shares in the company, valued at approximately $1,373,814.60. The disclosure for this sale can be found here. In the last ninety days, insiders sold 24,262 shares of company stock valued at $2,545,532. Company insiders own 6.70% of the company’s stock.

ICU Medical Stock Down 1.1 %

Shares of NASDAQ ICUI opened at $97.10 on Tuesday. ICU Medical, Inc. has a one year low of $78.28 and a one year high of $212.43. The stock has a market capitalization of $2.37 billion, a P/E ratio of -78.94 and a beta of 0.69. The firm’s 50 day simple moving average is $102.45 and its two-hundred day simple moving average is $98.97. The company has a debt-to-equity ratio of 0.74, a current ratio of 2.53 and a quick ratio of 1.06.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings results on Tuesday, February 27th. The medical instruments supplier reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.85 by $0.39. ICU Medical had a positive return on equity of 6.35% and a negative net margin of 1.31%. The business had revenue of $587.86 million for the quarter, compared to analyst estimates of $564.77 million. As a group, analysts expect that ICU Medical, Inc. will post 3.52 EPS for the current fiscal year.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.